Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 15;11(9):729-740.
doi: 10.4251/wjgo.v11.i9.729.

Colorectal cancer fecal screening test completion after age 74, sources and outcomes in French program

Affiliations

Colorectal cancer fecal screening test completion after age 74, sources and outcomes in French program

Akoï Koïvogui et al. World J Gastrointest Oncol. .

Abstract

Background: Elderly patients aged at least 75 years old (Elderly_75), represent 45% of colorectal cancer (CRC) incidence. As others, the French Colorectal Cancer Screening Program (CRCSP) does not include Elderly_75. To date, there is little evidence to justify stopping screening at 74 years of age.

Aim: To describe CRC fecal screening test completion after age 74, source (CRCSP/Provider ordered) and outcomes of these tests.

Methods: The study concerned 18704 Elderly_75 residing in eleven French districts (Ain, Doubs, Essonne, Haute-Saone, Hauts-de-Seine, Jura, Seine-Saint-Denis, Territoire-de-Belfort, Val-de-Marne, Val-d'Oise, Yonne), having performed a CRC screening test between January 2008 and December 2017. The tests performed in a circumstance of delayed response to a solicitation (DRS) from the local cancer screening managing center (Managing-Center) were distinguished from the tests non-solicited by the Managing-Center, performed after a recommendation by a General Practitioner (GP) or other provider ordered (RGP). DRS was any test realized by an Elderly_75 following an initial invitation from the Managing-Center with a maximum 24 mo after this invitation. Any Non-DRS test was considered RGP. The outcomes of these tests were described according to the circumstances of test completion.

Results: Of 18995 screening-tests were performed at ages: 75 (83.5%), 76-80 (13.4%) and > 80 (3.1%) years old. Elderly_75 performed the screening test in a circumstance of DRS (71.9%) or RGP (28.1%). The proportion of the tests that could not be analyzed and not restarted was 13.2%. For these unanalyzed tests, the reason was age-related in 78.0% of cases, related to the laboratory's refusal to analyze the test of people aged ≥ 77. Reported colonoscopy completion rate was 81.3%. For those 575 people with reported colonoscopy, no complication was listed. 18.0% of the 366 Elderly_75 with lesions had no anteriority in the CRCSP. The neoplasia (124 Low-risk-polyps, 159 High-risk-polyps, 13 Unspecified-polyps and 70 CRCs) detection rate was 19.3/1000 Elderly_75 screened and the CRC detection rate was 3.7/1000 Elderly_75 screened.

Conclusion: The high rate of colonoscopy completion after a positive test and the high proportion of screened lesions observed suggest that the lengthening of the screening period could allow significant detection of CRC and polyps that occur in Elderly_75 excluded from CRCSP.

Keywords: Colonoscopy completion rate; Colorectal cancer; Elderly; Fecal screening test; Participation rate.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Frequency of participation in previous campaigns, by circumstances and by screening year. DRS: Delayed response after solicitation; RGP: Recommendation of a General Practitioner/Provider ordered; CI: Confidence interval.

References

    1. Binder-Foucard F, Belot A, Delafosse P, Remontet L, Woronoff A-S, Bossard N. 2013. Estimation nationale de l’incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1-Tumeurs solides [cited 04 December 2018]. Saint-Maurice (Fra), Institut de veille sanitaire; p. 122. Available from: http://big.assets.huffingtonpost.com/estimationnational.pdf.
    1. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674–1680. - PubMed
    1. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477. - PubMed
    1. Castiglione G, Zappa M, Ciatto S. Comments on: Recommendations on colorectal cancer (CRC)screening in the European Union. Advisory Committee on Cancer Prevention. Eur J Cancer 2000, 36, 1473-1478. Eur J Cancer. 2001;37:438–439. - PubMed
    1. Pox C, Schmiegel W. Colorectal screening in Germany. Z Gastroenterol. 2008;46 Suppl 1:S31–S32. - PubMed